Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Six new Gaucher disease mutations

A Demina1, E Beutler

  • 1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, Calif 92037, USA.

Acta Haematologica
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effectiveness of lucid dreaming therapy in patients with nightmares: A systematic review.

L'Encephale·2023
Same author

Coincidence of Gaucher's disease due to a private mutation and Ph' positive chronic myeloid leukemia.

American journal of hematology·1998
Same author

Six previously undescribed pyruvate kinase mutations causing enzyme deficiency.

Blood·1998
Same author

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

Structure and linkage relationships of the region containing the human L-type pyruvate kinase (PKLR) and glucocerebrosidase (GBA) genes.

Hematopathology and molecular hematology·1998
Same author

Molecular analysis of Gaucher disease: distribution of eight mutations and the complete gene deletion in 27 patients from Germany.

Human genetics·1997
Same journal

Dapagliflozin in Patients with homozygous β-Thalassemia and Albuminuria.

Acta haematologica·2026
Same journal

Efficacy of second-generation FLT3 inhibitors in FLT3-mutated AML: A meta-analysis of randomized controlled trials.

Acta haematologica·2026
Same journal

Limited prognostic value of ELN classification and relevance of molecular ontogeny in acute myeloid leukemia post myeloproliferative neoplasms: a retrospective multicenter study.

Acta haematologica·2026
Same journal

Real-World Data on First Relapse in Multiple Myeloma: Treatment Patterns and Outcomes in Finland Using Automated Data Collection.

Acta haematologica·2026
Same journal

Comparative efficacy of donor lymphocyte infusions in augmenting graft-versus-leukemia effect after allogeneic hematopoietic stem cell transplantation for patients with myeloid malignancies.

Acta haematologica·2026
Same journal

COVID-19 infection in patients with follicular lymphoma and related indolent B-cell lymphomas receiving anti-CD20 monoclonal antibody maintenance therapy.

Acta haematologica·2026
See all related articles

Six new Gaucher disease mutations were found in six patients. These genetic changes contribute to Gaucher disease, affecting patients with mild symptoms or central nervous system involvement.

Area of Science:

  • Genetics
  • Molecular Biology
  • Rare Diseases

Background:

  • Gaucher disease is a lysosomal storage disorder caused by mutations in the GBA gene.
  • Genetic heterogeneity contributes to the diverse clinical manifestations of Gaucher disease.

Purpose of the Study:

  • To identify and characterize novel mutations in the GBA gene in patients with Gaucher disease.
  • To correlate identified mutations with clinical phenotypes.

Main Methods:

  • DNA sequencing of the GBA gene in six unrelated Gaucher disease patients.
  • Genotype-phenotype correlation analysis.

Main Results:

  • Six previously undescribed mutations were identified: 437C-->T, 593C-->T, 604C-->T, 1138G-->A, 1214G-->A, and 1294T-->A.

Related Experiment Videos

  • Four patients presented with type I Gaucher disease (mild phenotype), while two patients exhibited central nervous system involvement (type II and III).
  • One patient was homozygous for the 593C-->T mutation, and five were compound heterozygotes.

    • Conclusions:

    • Novel mutations in the GBA gene contribute to the genetic landscape of Gaucher disease.
    • The identified mutations are associated with varying clinical severity, including mild type I and severe neurological forms.